Laboratory Science and Pathology Committee

The Laboratory Science and Pathology Committee coordinates all of the biomarker activities of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the biorepositories that support this research. Its primary role in the Group is to increase the scientific value of its trials by encouraging, facilitating, integrating, coordinating, and prioritizing translational science that will lead to the use of biomarkers in studies.

Experts in somatic genetics, circulating tumor analyses, and immunologic assay development participate in this committee. They identify novel imaging, DNA, RNA, and protein-based biomarkers that define discrete patient populations, then explore them as integral biomarkers in ECOG-ACRIN trials. They evaluate the performance characteristics of such novel diagnostics for subsequent implementation in routine clinical practice.

The Group's network of tissue and specimen banks and translational science programs complements the work of this committee. To learn more, visit the Research Cores / Support section.


Edmund C. Lattime, PhD

Rutgers Cancer Institute of New Jersey

Laboratory Science and Pathology CommitteeLaboratory Science and Pathology Committee
ECOG-ACRIN Cancer Research Group